With HER2 being the prototypical gastric cancer biomarker, studies have suggested increasing endoscopic sampling of ≥4 biopsy fragments can increase the sensitivity of detecting tumor HER2 overexpression (12). The gene discussed is ERBB2; the disease is neoplasm.